FIGURE 1—

Methadone and Buprenorphine Treatment Characteristics Among Rhode Island Residents Who Died of an Accidental Opioid-Related Overdose: Rhode Island, January 1, 2018–June 30, 2020

Note. OAT = opioid agonist therapy. The sample size was n = 626.

^aIncludes buprenorphine products Food and Drug Administration–approved for opioid agonist therapy dispensed between April 1, 2016, and June 30, 2020, and methadone treatment received between January 1, 2010, and June 30, 2020. ^bLimited to individuals who received buprenorphine or methadone treatment. Calculated from the last day an individual received methadone treatment or the fill date of the buprenorphine prescription and the days’ supply.